Aditi Dutt

Array ( [id] => 9122100 [patent_doc_number] => 20130289022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'TETRAMERIC ALPHA-SYNUCLEIN AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/883552 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 160 [patent_figures_cnt] => 160 [patent_no_of_words] => 35671 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003072 [patent_doc_number] => 20130224197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'Methods for treatment of brain injury utilizing biologics' [patent_app_type] => utility [patent_app_number] => 13/848044 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17130 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733308 [patent_doc_number] => 20120015882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPOSITION FOR REGULATING AUTONOMIC NERVOUS ACTIVITY AND METHOD FOR REGULATING AUTONOMIC NERVE' [patent_app_type] => utility [patent_app_number] => 13/245449 [patent_app_country] => US [patent_app_date] => 2011-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6339 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015882.pdf [firstpage_image] =>[orig_patent_app_number] => 13245449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776250 [patent_doc_number] => 20120039859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Method of Diminishing The Symptoms of Neurodegenerative Disease' [patent_app_type] => utility [patent_app_number] => 13/230489 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10158 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039859.pdf [firstpage_image] =>[orig_patent_app_number] => 13230489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300984 [patent_doc_number] => 20120183542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'TREATING NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/222097 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21597 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13222097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657332 [patent_doc_number] => 20110306601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'PHARMACOLOGICAL MODULATION OF POSITIVE AMPA RECEPTOR MODULATOR EFFECTS ON NEUROTROPHIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/213419 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29741 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306601.pdf [firstpage_image] =>[orig_patent_app_number] => 13213419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719831 [patent_doc_number] => 20120009166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'Isolated monocyte populations and related therapeutic applications' [patent_app_type] => utility [patent_app_number] => 13/136940 [patent_app_country] => US [patent_app_date] => 2011-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12302 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009166.pdf [firstpage_image] =>[orig_patent_app_number] => 13136940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754811 [patent_doc_number] => 20120027848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use' [patent_app_type] => utility [patent_app_number] => 13/193346 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17725 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027848.pdf [firstpage_image] =>[orig_patent_app_number] => 13193346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754811 [patent_doc_number] => 20120027848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use' [patent_app_type] => utility [patent_app_number] => 13/193346 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17725 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027848.pdf [firstpage_image] =>[orig_patent_app_number] => 13193346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754811 [patent_doc_number] => 20120027848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use' [patent_app_type] => utility [patent_app_number] => 13/193346 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17725 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027848.pdf [firstpage_image] =>[orig_patent_app_number] => 13193346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754811 [patent_doc_number] => 20120027848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Enzyme Delivery Systems and Methods of Preparation and Use' [patent_app_type] => utility [patent_app_number] => 13/193346 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17725 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027848.pdf [firstpage_image] =>[orig_patent_app_number] => 13193346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653203 [patent_doc_number] => 08372953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Composition comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof' [patent_app_type] => utility [patent_app_number] => 13/181387 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 9290 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13181387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858391 [patent_doc_number] => 08460925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Methods for culturing mammalian taste cells' [patent_app_type] => utility [patent_app_number] => 13/180911 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11900 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903674 [patent_doc_number] => 20130171177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Therapeutic Use of Neural Stem Cells' [patent_app_type] => utility [patent_app_number] => 13/701932 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5191 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792079 [patent_doc_number] => 20130109048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'METHOD FOR IN-VITRO MONITORING OF NEURONAL DISORDERS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/809315 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11974 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720813 [patent_doc_number] => 20120010148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'COMBINATION THERAPIES USING NAP' [patent_app_type] => utility [patent_app_number] => 13/174167 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25346 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010148.pdf [firstpage_image] =>[orig_patent_app_number] => 13174167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11219137 [patent_doc_number] => 09447466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Method for determination or evaluation of test substance' [patent_app_type] => utility [patent_app_number] => 13/806979 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 7798 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814167 [patent_doc_number] => 20130115212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Modulation of the Interaction between SorLA and GDNF-Family Ligand Receptors' [patent_app_type] => utility [patent_app_number] => 13/702692 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21435 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9530010 [patent_doc_number] => 08753881 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Method for inducing differentiation of mesenchymal stem cells to nerve cells using sound waves' [patent_app_type] => utility [patent_app_number] => 13/702982 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 4422 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509146 [patent_doc_number] => 20120308554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'VEGF-D/VEGFR2/3-MEDIATED REGULATION OF DENDRITES' [patent_app_type] => utility [patent_app_number] => 13/150846 [patent_app_country] => US [patent_app_date] => 2011-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 13239 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13150846 [rel_patent_id] =>[rel_patent_doc_number] =>)